Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 May;84(10):1377–1383. doi: 10.1054/bjoc.2000.1580

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

Y Ito 1,2, T Takeda 1, M Sakon 3, M Tsujimoto 4, S Higashiyama 5, K Noda 6, E Miyoshi 6, M Monden 3, N Matsuura 2
PMCID: PMC2363640  PMID: 11355950

Abstract

In order to elucidate the clinical significance of the erbB family, epidermal growth factor receptor (EGF-R), c-erbB-2, c-erbB-3 and c-erbB-4 in hepatocellular carcinoma (HCC), we investigated the expression of these proteins by means of immunohistochemistry for HCC as well as adjacent noncancerous lesions. EGF-R was expressed in 68% of the HCC examined and showed correlation with the proliferating activity, stage, intrahepatic metastasis and carcinoma differentiation. c-erbB-2 was expressed in only 21% of the cases and showed no relationships with the clinicopathological parameters. c-erbB-3 protein was observed in 84% of the HCC and 38.1% of the noncancerous lesions. Its expression in HCC was equal to or greater than noncancerous lesions in 90.5% of the cases, and was related to the stage, portal invasion, cell proliferating activity, tumour size, intrahepatic metastasis and carcinoma differentiation. c-erbB-4 protein was expressed in 61.0% of HCC and in as much as 86.1% of the noncancerous lesions. Unlike the expression of c-erbB-3, that of c-erbB-4 in HCC was less than that of the adjacent noncancerous lesions in 51.2% of the cases. No statistical significance could be established between this protein expression in HCC and clinicopathological features. EGF-R and c-erbB-3 affected disease-free survival, but were not recognized as independent prognostic factors by multivariate analysis. The present study suggests that, of the four receptors, EGF-R and c-erbB-3 play important roles in the progression of HCC. © 2001 Cancer Research Campaign www.bjcancer.com

Keywords: EGF-R, c-erbB-2, c-erbB-3, c-erbB-4, hepatocellular carcinoma, immunohistochemistry

Full Text

The Full Text of this article is available as a PDF (451.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bacus S. S., Chin D., Yarden Y., Zelnick C. R., Stern D. F. Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors. Am J Pathol. 1996 Feb;148(2):549–558. [PMC free article] [PubMed] [Google Scholar]
  2. Baulida J., Kraus M. H., Alimandi M., Di Fiore P. P., Carpenter G. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J Biol Chem. 1996 Mar 1;271(9):5251–5257. doi: 10.1074/jbc.271.9.5251. [DOI] [PubMed] [Google Scholar]
  3. Beasley R. P., Hwang L. Y., Lin C. C., Chien C. S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981 Nov 21;2(8256):1129–1133. doi: 10.1016/s0140-6736(81)90585-7. [DOI] [PubMed] [Google Scholar]
  4. Berchuck A., Kamel A., Whitaker R., Kerns B., Olt G., Kinney R., Soper J. T., Dodge R., Clarke-Pearson D. L., Marks P. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res. 1990 Jul 1;50(13):4087–4091. [PubMed] [Google Scholar]
  5. Bobrow L. G., Millis R. R., Happerfield L. C., Gullick W. J. c-erbB-3 protein expression in ductal carcinoma in situ of the breast. Eur J Cancer. 1997 Oct;33(11):1846–1850. doi: 10.1016/s0959-8049(97)00244-x. [DOI] [PubMed] [Google Scholar]
  6. Bodey B., Bodey B., Jr, Gröger A. M., Luck J. V., Siegel S. E., Taylor C. R., Kaiser H. E. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas. Anticancer Res. 1997 Mar-Apr;17(2B):1319–1330. [PubMed] [Google Scholar]
  7. Borg A., Tandon A. K., Sigurdsson H., Clark G. M., Fernö M., Fuqua S. A., Killander D., McGuire W. L. HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res. 1990 Jul 15;50(14):4332–4337. [PubMed] [Google Scholar]
  8. Brunt E. M., Swanson P. E. Immunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver. Am J Clin Pathol. 1992 May;97(5 Suppl 1):S53–S61. [PubMed] [Google Scholar]
  9. Cantley L. C., Auger K. R., Carpenter C., Duckworth B., Graziani A., Kapeller R., Soltoff S. Oncogenes and signal transduction. Cell. 1991 Jan 25;64(2):281–302. doi: 10.1016/0092-8674(91)90639-g. [DOI] [PubMed] [Google Scholar]
  10. Chang C. P., Lazar C. S., Walsh B. J., Komuro M., Collawn J. F., Kuhn L. A., Tainer J. A., Trowbridge I. S., Farquhar M. G., Rosenfeld M. G. Ligand-induced internalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors. J Biol Chem. 1993 Sep 15;268(26):19312–19320. [PubMed] [Google Scholar]
  11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  12. Chow N. H., Liu H. S., Yang H. B., Chan S. H., Su I. J. Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma. An immunohistochemical study. Virchows Arch. 1997 Jun;430(6):461–466. doi: 10.1007/s004280050056. [DOI] [PubMed] [Google Scholar]
  13. Collier J. D., Guo K., Mathew J., May F. E., Bennett M. K., Corbett I. P., Bassendine M. F., Burt A. D. c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma. J Hepatol. 1992 Mar;14(2-3):377–380. doi: 10.1016/0168-8278(92)90186-s. [DOI] [PubMed] [Google Scholar]
  14. Dugan M. C., Dergham S. T., Kucway R., Singh K., Biernat L., Du W., Vaitkevicius V. K., Crissman J. D., Sarkar F. H. HER-2/neu expression in pancreatic adenocarcinoma: relation to tumor differentiation and survival. Pancreas. 1997 Apr;14(3):229–236. doi: 10.1097/00006676-199704000-00003. [DOI] [PubMed] [Google Scholar]
  15. Elenius K., Paul S., Allison G., Sun J., Klagsbrun M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 1997 Mar 17;16(6):1268–1278. doi: 10.1093/emboj/16.6.1268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Friess H., Fukuda A., Tang W. H., Eichenberger A., Furlan N., Zimmermann A., Korc M., Büchler M. W. Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3. World J Surg. 1999 Oct;23(10):1010–1018. doi: 10.1007/s002689900616. [DOI] [PubMed] [Google Scholar]
  17. Haugen D. R., Akslen L. A., Varhaug J. E., Lillehaug J. R. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas. Cancer Res. 1996 Mar 15;56(6):1184–1188. [PubMed] [Google Scholar]
  18. Häussler O., Epstein J. I., Amin M. B., Heitz P. U., Hailemariam S. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer. Hum Pathol. 1999 Sep;30(9):1077–1086. doi: 10.1016/s0046-8177(99)90226-5. [DOI] [PubMed] [Google Scholar]
  19. Ibrahim S. O., Vasstrand E. N., Liavaag P. G., Johannessen A. C., Lillehaug J. R. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck. Anticancer Res. 1997 Nov-Dec;17(6D):4539–4546. [PubMed] [Google Scholar]
  20. Ito Y., Matsuura N., Sakon M., Takeda T., Umeshita K., Nagano H., Nakamori S., Dono K., Tsujimoto M., Nakahara M. Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma. Br J Cancer. 1999 Oct;81(4):747–751. doi: 10.1038/sj.bjc.6690758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kameda T., Yasui W., Yoshida K., Tsujino T., Nakayama H., Ito M., Ito H., Tahara E. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification. Cancer Res. 1990 Dec 15;50(24):8002–8009. [PubMed] [Google Scholar]
  22. Kapitanović S., Radosević S., Slade N., Kapitanović M., Andelinović S., Ferencić Z., Tavassoli M., Spaventi S., Pavelić K., Spaventi R. Expression of erbB-3 protein in colorectal adenocarcinoma: correlation with poor survival. J Cancer Res Clin Oncol. 2000 Apr;126(4):205–211. doi: 10.1007/s004320050034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kern J. A., Schwartz D. A., Nordberg J. E., Weiner D. B., Greene M. I., Torney L., Robinson R. A. p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res. 1990 Aug 15;50(16):5184–5187. [PubMed] [Google Scholar]
  24. Kew T. Y., Bell J. A., Pinder S. E., Denley H., Srinivasan R., Gullick W. J., Nicholson R. I., Blamey R. W., Ellis I. O. c-erbB-4 protein expression in human breast cancer. Br J Cancer. 2000 Mar;82(6):1163–1170. doi: 10.1054/bjoc.1999.1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kim H. H., Sierke S. L., Koland J. G. Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product. J Biol Chem. 1994 Oct 7;269(40):24747–24755. [PubMed] [Google Scholar]
  26. Kira S., Nakanishi T., Suemori S., Kitamoto M., Watanabe Y., Kajiyama G. Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma. Liver. 1997 Aug;17(4):177–182. doi: 10.1111/j.1600-0676.1997.tb00803.x. [DOI] [PubMed] [Google Scholar]
  27. Komurasaki T., Toyoda H., Uchida D., Morimoto S. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4. Oncogene. 1997 Dec 4;15(23):2841–2848. doi: 10.1038/sj.onc.1201458. [DOI] [PubMed] [Google Scholar]
  28. Kraus M. H., Issing W., Miki T., Popescu N. C., Aaronson S. A. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9193–9197. doi: 10.1073/pnas.86.23.9193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lee C. S., Pirdas A. Epidermal growth factor receptor immunoreactivity in gallbladder and extrahepatic biliary tract tumours. Pathol Res Pract. 1995 Nov;191(11):1087–1091. doi: 10.1016/S0344-0338(11)80652-7. [DOI] [PubMed] [Google Scholar]
  30. Nakopoulou L., Stefanaki K., Filaktopoulos D., Giannopoulou I. C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study. Histol Histopathol. 1994 Oct;9(4):677–682. [PubMed] [Google Scholar]
  31. Pinkas-Kramarski R., Soussan L., Waterman H., Levkowitz G., Alroy I., Klapper L., Lavi S., Seger R., Ratzkin B. J., Sela M. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J. 1996 May 15;15(10):2452–2467. [PMC free article] [PubMed] [Google Scholar]
  32. Plowman G. D., Culouscou J. M., Whitney G. S., Green J. M., Carlton G. W., Foy L., Neubauer M. G., Shoyab M. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1746–1750. doi: 10.1073/pnas.90.5.1746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Riese D. J., 2nd, Bermingham Y., van Raaij T. M., Buckley S., Plowman G. D., Stern D. F. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene. 1996 Jan 18;12(2):345–353. [PubMed] [Google Scholar]
  34. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6547–6549. doi: 10.1073/pnas.87.17.6547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sanidas E. E., Filipe M. I., Linehan J., Lemoine N. R., Gullick W. J., Rajkumar T., Levison D. A. Expression of the c-erbB-3 gene product in gastric cancer. Int J Cancer. 1993 Jul 30;54(6):935–940. doi: 10.1002/ijc.2910540612. [DOI] [PubMed] [Google Scholar]
  36. Sasaki K., Murakami T., Kawasaki M., Takahashi M. The cell cycle associated change of the Ki-67 reactive nuclear antigen expression. J Cell Physiol. 1987 Dec;133(3):579–584. doi: 10.1002/jcp.1041330321. [DOI] [PubMed] [Google Scholar]
  37. Shintani S., Funayama T., Yoshihama Y., Alcalde R. E., Ootsuki K., Terakado N., Matsumura T. Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: an immunohistochemical study. Anticancer Res. 1995 Nov-Dec;15(6B):2623–2626. [PubMed] [Google Scholar]
  38. Simpson B. J., Phillips H. A., Lessells A. M., Langdon S. P., Miller W. R. c-erbB growth-factor-receptor proteins in ovarian tumours. Int J Cancer. 1995 Jun 22;64(3):202–206. doi: 10.1002/ijc.2910640310. [DOI] [PubMed] [Google Scholar]
  39. Soltoff S. P., Carraway K. L., 3rd, Prigent S. A., Gullick W. G., Cantley L. C. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol Cell Biol. 1994 Jun;14(6):3550–3558. doi: 10.1128/mcb.14.6.3550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Srinivasan R., Benton E., McCormick F., Thomas H., Gullick W. J. Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 alpha, neuregulin-1 beta, and betacellulin, in normal endometrium and endometrial cancer. Clin Cancer Res. 1999 Oct;5(10):2877–2883. [PubMed] [Google Scholar]
  41. Srinivasan R., Gillett C. E., Barnes D. M., Gullick W. J. Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers. Cancer Res. 2000 Mar 15;60(6):1483–1487. [PubMed] [Google Scholar]
  42. Srinivasan R., Poulsom R., Hurst H. C., Gullick W. J. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Pathol. 1998 Jul;185(3):236–245. doi: 10.1002/(SICI)1096-9896(199807)185:3<236::AID-PATH118>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  43. Suo Z., Emilsen E., Tveit K. M., Nesland J. M. Type 1 protein tyrosine kinases in benign and malignant breast lesions. Histopathology. 1998 Dec;33(6):514–521. doi: 10.1046/j.1365-2559.1998.00498.x. [DOI] [PubMed] [Google Scholar]
  44. Terada T., Ashida K., Endo K., Horie S., Maeta H., Matsunaga Y., Takashima K., Ohta T., Kitamura Y. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma. Histopathology. 1998 Oct;33(4):325–331. doi: 10.1046/j.1365-2559.1998.00496.x. [DOI] [PubMed] [Google Scholar]
  45. Travis A., Pinder S. E., Robertson J. F., Bell J. A., Wencyk P., Gullick W. J., Nicholson R. I., Poller D. N., Blamey R. W., Elston C. W. C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators. Br J Cancer. 1996 Jul;74(2):229–233. doi: 10.1038/bjc.1996.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990 Apr 20;61(2):203–212. doi: 10.1016/0092-8674(90)90801-k. [DOI] [PubMed] [Google Scholar]
  47. Uwaifo A. O., Bababunmi E. A. Liver carcinogenesis in tropical Africa. IARC Sci Publ. 1984;(63):59–88. [PubMed] [Google Scholar]
  48. Yang J. L., Yu Y., Markovic B., Russell P. J., Crowe P. J. Overexpression of c-erbB-2 mRNA and/or c-neu oncoprotein is a predictor for metastases from colorectal cancer. Anticancer Res. 1997 Mar-Apr;17(2A):1023–1026. [PubMed] [Google Scholar]
  49. Zhang D., Sliwkowski M. X., Mark M., Frantz G., Akita R., Sun Y., Hillan K., Crowley C., Brush J., Godowski P. J. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9562–9567. doi: 10.1073/pnas.94.18.9562. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES